JP2024529479A - 膣挿入のための組成物及び技術 - Google Patents

膣挿入のための組成物及び技術 Download PDF

Info

Publication number
JP2024529479A
JP2024529479A JP2024505214A JP2024505214A JP2024529479A JP 2024529479 A JP2024529479 A JP 2024529479A JP 2024505214 A JP2024505214 A JP 2024505214A JP 2024505214 A JP2024505214 A JP 2024505214A JP 2024529479 A JP2024529479 A JP 2024529479A
Authority
JP
Japan
Prior art keywords
composition
poloxamer
composition according
less
active ingredient
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024505214A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024529479A5 (https=
Inventor
フレンド，デイビッド
キアン，ジェニファー
パセリ，ニコラス，ジェイ．
ウォルターズ，マーク
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of JP2024529479A publication Critical patent/JP2024529479A/ja
Publication of JP2024529479A5 publication Critical patent/JP2024529479A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Urology & Nephrology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP2024505214A 2021-07-26 2022-07-25 膣挿入のための組成物及び技術 Pending JP2024529479A (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US202163225872P 2021-07-26 2021-07-26
US63/225,872 2021-07-26
US202163285447P 2021-12-02 2021-12-02
US63/285,447 2021-12-02
US202263331749P 2022-04-15 2022-04-15
US63/331,749 2022-04-15
PCT/US2022/038234 WO2023009461A2 (en) 2021-07-26 2022-07-25 Compositions and techniques for vaginal insertion

Publications (2)

Publication Number Publication Date
JP2024529479A true JP2024529479A (ja) 2024-08-06
JP2024529479A5 JP2024529479A5 (https=) 2025-12-18

Family

ID=82899311

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024505214A Pending JP2024529479A (ja) 2021-07-26 2022-07-25 膣挿入のための組成物及び技術

Country Status (5)

Country Link
US (1) US20240189265A1 (https=)
EP (1) EP4376890A2 (https=)
JP (1) JP2024529479A (https=)
AU (1) AU2022319690A1 (https=)
WO (1) WO2023009461A2 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2024155777A2 (en) * 2023-01-19 2024-07-25 Dare Bioscience, Inc. Compositions and techniques for treatment of polycystic ovarian syndrome (pcos) and endometriosis
WO2024155775A2 (en) * 2023-01-19 2024-07-25 Dare Bioscience, Inc. Compositions and techniques for treatment of polycystic ovarian syndrome (pcos) and endometriosis
WO2024158951A2 (en) * 2023-01-25 2024-08-02 Dare Bioscience, Inc. Compositions and methods for treating dysmenorrhea
WO2025212773A1 (en) * 2024-04-03 2025-10-09 Daré Bioscience, Inc. Lactobacillus gel formulation and uses thereof

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2520279A1 (en) * 2011-05-02 2012-11-07 TERES S.r.l. Thermoreversible gel pharamaceutical compositions for odontoiatric use
US20180207275A1 (en) * 2015-07-20 2018-07-26 Trilogic Pharma Llc Topical formulations and treatments

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6825234B2 (en) * 1998-12-10 2004-11-30 Nexmed (Holdings) , Inc. Compositions and methods for amelioration of human female sexual dysfunction
US20030206958A1 (en) * 2000-12-22 2003-11-06 Cattaneo Maurizio V. Chitosan biopolymer for the topical delivery of active agents
US20060189552A1 (en) * 2000-12-12 2006-08-24 Mohan Vishnupad Dispenser for dispensing three or more actives
EP2010133B1 (en) * 2006-03-31 2016-05-04 Stiefel Research Australia Pty Ltd Foamable suspension gel
EA030035B1 (ru) * 2007-11-06 2018-06-29 Меламед, Лемуил Применение s-этилизотиоурония диэтилфосфата для изготовления лекарственного средства для лечения нарушения матки
EP2242476A2 (en) * 2008-01-14 2010-10-27 Foamix Ltd. Poloxamer foamable pharmaceutical compositions with active agents and/or therapeutic cells and uses
WO2014042604A1 (en) * 2012-09-11 2014-03-20 Imuneks Farma Mac Sanayi Ve Ticaret A.S. Clindamycin phosphate, salicylic acid and tea tree oil combinations
AU2013362794B2 (en) * 2012-12-20 2018-02-22 Smilesonica Inc. Internal ultrasound gel
BR112021008100A2 (pt) * 2018-11-05 2021-08-03 Inspired Material Solutions, LLC carreador e protetor de pele dérmico

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2520279A1 (en) * 2011-05-02 2012-11-07 TERES S.r.l. Thermoreversible gel pharamaceutical compositions for odontoiatric use
US20180207275A1 (en) * 2015-07-20 2018-07-26 Trilogic Pharma Llc Topical formulations and treatments

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
医療用医薬品 :ボルタレン 添付文書情報, JPN6026010433, 11 April 2021 (2021-04-11), ISSN: 0005818552 *

Also Published As

Publication number Publication date
AU2022319690A1 (en) 2024-03-14
WO2023009461A2 (en) 2023-02-02
US20240189265A1 (en) 2024-06-13
EP4376890A2 (en) 2024-06-05
WO2023009461A3 (en) 2023-07-13

Similar Documents

Publication Publication Date Title
JP2024529479A (ja) 膣挿入のための組成物及び技術
JP4891765B2 (ja) 半固体粘膜接着製剤
Baloglu et al. Strategies to prolong the intravaginal residence time of drug delivery systems
CN100488517C (zh) 捕获和灭活病原性微生物和精子的组合物及其制药用途
EP2359807B1 (en) Monolithic intravaginal rings comprising progesterone and methods of making and uses thereof
JP2013100364A (ja) ヒトの分娩を容易にするための新規組成物
RO109156B1 (ro) Compozitie cu metronidazol,pentru infectiile vaginale si metoda de tratament cu aceasta
Abd Ellah et al. Dual-responsive lidocaine in situ gel reduces pain of intrauterine device insertion
CN101175503A (zh) 一种调节并保持阴道菌群和阴道酸度正常的组合物与方法
US20240165141A1 (en) Systems and methods for treatment of bacterial vaginosis
BR112012008040B1 (pt) composição antimicrobiana aquosa
JP2020147569A (ja) 変性グアーガムを用いる医薬ソフトゼラチンカプセル剤形
Ahmad et al. Development and in vitro evaluation of an acid buffering bioadhesive vaginal gel for mixed vaginal infections
JP6149109B2 (ja) 乳酸オリゴマー含有医薬組成物
De Cramer Surgical uterine drainage and lavage as treatment for canine pyometra: clinical communication
Shapiro et al. Locally administered nanosuspension increases delivery of estradiol for the treatment of vaginal atrophy in mice
CA3227295A1 (en) Compositions and techniques for vaginal insertion
CN118317794A (zh) 用于治疗痛经的组合物
CN1929815B (zh) 用于阴道治疗的含磷酸甘露糖组合物
Shitut et al. Rectal and Vaginal Routes of Drug Delivery
WO2024158951A2 (en) Compositions and methods for treating dysmenorrhea
Dodou Rectal and vaginal drug delivery
WO2024155777A2 (en) Compositions and techniques for treatment of polycystic ovarian syndrome (pcos) and endometriosis
WO2024155775A2 (en) Compositions and techniques for treatment of polycystic ovarian syndrome (pcos) and endometriosis
Khasraghi Formulation and In Vitro Evaluation of Mucoadhesive Nystatin Vaginal Gel

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20250725

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20250725

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20251209

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20260317